Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study.

2.50
Hdl Handle:
http://hdl.handle.net/10029/621959
Title:
Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study.
Authors:
Monge, Susana; Hahné, Susan Jm; de Melker, Hester E; Sanders, Elisabeth Am; van der Ende, Arie; Knol, Mirjam J
Abstract:
In 2016, an increase in invasive Haemophilus influenzae serotype b (Hib) disease was reported in the Netherlands in children younger than 5 years, which coincided with the introduction of the hexavalent diphtheria, tetanus, and acellular pertussis-hepatitis B virus-inactivated polio virus/Hib vaccine (DTPa-HBV-IPV/Hib) from 2011 onwards. We aimed to estimate the effectiveness of the hexavalent vaccine to assess whether this increase could be explained by decreasing effectiveness.
Citation:
Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study. 2018 Lancet Infect Dis
Journal:
Lancet Infect Dis 2018; advance online publication (ahead of print)
Issue Date:
8-May-2018
URI:
http://hdl.handle.net/10029/621959
DOI:
10.1016/S1473-3099(18)30166-X
PubMed ID:
29752131
Type:
Article
Language:
en
ISSN:
1474-4457
Appears in Collections:
Miscellaneous

Full metadata record

DC FieldValue Language
dc.contributor.authorMonge, Susanaen
dc.contributor.authorHahné, Susan Jmen
dc.contributor.authorde Melker, Hester Een
dc.contributor.authorSanders, Elisabeth Amen
dc.contributor.authorvan der Ende, Arieen
dc.contributor.authorKnol, Mirjam Jen
dc.date.accessioned2018-05-27T13:17:58Z-
dc.date.available2018-05-27T13:17:58Z-
dc.date.issued2018-05-08-
dc.identifier.citationEffectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study. 2018 Lancet Infect Disen
dc.identifier.issn1474-4457-
dc.identifier.pmid29752131-
dc.identifier.doi10.1016/S1473-3099(18)30166-X-
dc.identifier.urihttp://hdl.handle.net/10029/621959-
dc.description.abstractIn 2016, an increase in invasive Haemophilus influenzae serotype b (Hib) disease was reported in the Netherlands in children younger than 5 years, which coincided with the introduction of the hexavalent diphtheria, tetanus, and acellular pertussis-hepatitis B virus-inactivated polio virus/Hib vaccine (DTPa-HBV-IPV/Hib) from 2011 onwards. We aimed to estimate the effectiveness of the hexavalent vaccine to assess whether this increase could be explained by decreasing effectiveness.en
dc.language.isoenen
dc.rightsinfo:eu-repo/semantics/closedAccessen
dc.titleEffectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study.en
dc.typeArticleen
dc.identifier.journalLancet Infect Dis 2018; advance online publication (ahead of print)en

Related articles on PubMed

All Items in WARP are protected by copyright, with all rights reserved, unless otherwise indicated.